Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor
Beatty, P.G.; Kim, B.S.; Rowley, D.A.; Coppleson, L.W.
Journal of Immunology 116(5): 1391-1396
1976
ISSN/ISBN: 0022-1767 PMID: 1270800 Document Number: 104073
A transplantable plasmacytoma, TEPC-15 in BALB/c mice, induces a transient antibody response directed against the combining region of the myeloma protein produced by the tumor. Mice immunized with mitomycin-treated tumor cells produce similar antibody but do not develop tumor; mice so immunized survive longer than untreated mice when inoculated with viable TEPC-15 cells. This protection afforded by immunization can be transferred by serum alone; the protective effect of passively given serum is eliminated by absorbing out antibody directed against the myeloma protein.